0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 21
  • 12
  • 9
  • 9
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

9
9
55
68

PUBLISHED

1
19
41
68

PRODUCT TYPE

59
6
3

Search for: "Athersys, Inc.-Therapeutic Competitors"

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the...

Published:  May 2016
Price:  From

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2015 Summary The report ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2015’, provides an overview...

Published:  August 2015
Price:  From

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015’, provides an overview of the...

Published:  January 2015
Price:  From

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016 Summary ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016’, provides an overview of the Mucopolysaccharidosis...

Published:  June 2016
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015 Summary The report ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015’, provides an overview of the Graft Versus Host Disease...

Published:  September 2015
Price:  From

Athersys, Incorporation

A textual analysis of the financial results for Athersys, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio...

Published:  June 2016
Price:  From

Acute Respiratory Distress Syndrome - Pipeline Review, H2 2015

Acute Respiratory Distress Syndrome - Pipeline Review, H2 2015 Summary The authors, ‘Acute Respiratory Distress Syndrome - Pipeline Review, H2 2015’, provides an overview of the Acute Respiratory...

Published:  October 2015
Price:  From

Acute Respiratory Distress Syndrome - Pipeline Review, H1 2016

Acute Respiratory Distress Syndrome - Pipeline Review, H1 2016 Summary The report ‘Acute Respiratory Distress Syndrome - Pipeline Review, H1 2016’, provides an overview of the Acute Respiratory Distress...

Published:  February 2016
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016 Summary ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline...

Published:  March 2016
Price:  From

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015’, provides an overview of the Hematopoietic Stem...

Published:  May 2015
Price:  From

Myocardial Infarction - Pipeline Review, H1 2016

Myocardial Infarction - Pipeline Review, H1 2016 Summary ‘Myocardial Infarction - Pipeline Review, H1 2016’, provides an overview of the Myocardial Infarction pipeline landscape. The report provides...

Published:  April 2016
Price:  From

Multiple Sclerosis - Pipeline Review, H2 2015

Multiple Sclerosis - Pipeline Review, H2 2015 Summary The report ‘Multiple Sclerosis - Pipeline Review, H2 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Spinal Cord Injury - Pipeline Review, H1 2016

Spinal Cord Injury - Pipeline Review, H1 2016 Summary ‘Spinal Cord Injury - Pipeline Review, H1 2016’, provides an overview of the Spinal Cord Injury pipeline landscape. The report provides comprehensive...

Published:  May 2016
Price:  From

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016 Summary ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016’, provides an overview of the Hematopoietic Stem Cell...

Published:  April 2016
Price:  From

Ischemic Stroke - Pipeline Review, H1 2015

Ischemic Stroke - Pipeline Review, H1 2015 Summary: This, ‘Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides...

Published:  March 2015
Price:  From

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2016

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2016 Summary ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1...

Published:  May 2016
Price:  From

Cesca Therapeutics Inc. (KOOL) - Financial and Strategic SWOT Analysis Review

Cesca Therapeutics Inc. (KOOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  May 2016
Price:  From

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015 Summary The report ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015’, provides an overview of the Peripheral...

Published:  September 2015
Price:  From

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

Published:  March 2015
Price:  From

Ischemia - Pipeline Review, H2 2015

Ischemia - Pipeline Review, H2 2015 Summary The report ‘Ischemia - Pipeline Review, H2 2015’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

Published:  December 2015
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation